Kana Hayashi

Peripheral PD1-positive CD4 T-Lymphocyte Count Can Predict Progression-free Survival in Patients With Non-small Cell Lung Cancer Receiving Immune Checkpoint Inhibitor

Minehiko Inomata, Tomonobu Kado, Seisuke Okazawa et al. · Anticancer Research · 2019 · 46 citations · Full text

Life Sciences, Immunology, Oncology +17

(−)-Epigallocatechin gallate reduces transforming growth factor β-stimulated HSP27 induction through the suppression of stress-activated protein kinase/c-Jun N-terminal kinase in osteoblasts

Kana Hayashi, Shinji Takai, Rie Matsushima‐Nishiwaki et al. · Life Sciences · 2008 · 27 citations

Life Sciences, Cell Biology, Bone Metabolism +15

Peripheral CD4 memory T cells predict the efficacy of immune checkpoint inhibitor therapy in patients with non-small cell lung cancer

Minehiko Inomata, Masahiro Matsumoto, Naoki Takata et al. · Scientific Reports · 2023 · 20 citations · Full text

Medicine, Immunology, Oncology +17

Efficacy of immune checkpoint inhibitor therapy in patients with pulmonary sarcomatoid carcinoma in clinical practice

Minehiko Inomata, Takeshi Tsuda, Tomomi Ichikawa et al. · Thoracic Cancer · 2023 · 17 citations · Full text

Medicine, Oncology, Pharmacology +16

Association of Tumor PD-L1 Expression with the T790M Mutation and Progression-Free Survival in Patients with EGFR-Mutant Non-Small Cell Lung Cancer Receiving EGFR-TKI Therapy

Minehiko Inomata, Kenji Azechi, Naoki Takata et al. · Diagnostics · 2020 · 15 citations · Full text

Medicine, Oncology, Pharmacology +17